Drug intelligence / Profile preview

ribonuclease A

Development stage
Preclinical
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
01

Overview

Ribonuclease A (RNase A) is an endoribonuclease enzyme that catalyzes the hydrolysis of phosphodiester bonds in RNA molecules by cleaving at the 3' phosphate of pyrimidine nucleotides[3]. It is a single-chain polypeptide containing 4 disulfide bridges and exhibits highest activity with single-stranded RNA[3]. The enzyme is derived from bovine pancreas and is widely used in molecular biology applications including plasmid purification, genomic DNA isolation, removal of RNA from DNA samples, and diagnostic assay manufacturing[2]. RNase A has shown potential therapeutic applications including **antitumor activity** through its cytotoxic effects on cancer cells, as well as antimicrobial properties including antibacterial, antiviral, and antifungal activities[1]. The enzyme can be inhibited by alkylation of His12 or His119 residues in its active site[3]. Human RNase A family members (RNase 1-8) participate in various physiological and pathological processes including infection control, immune regulation, neurological function, and cardiovascular protection[1].

Other names
RNase Aribonuclease Ipancreatic ribonucleaseribonuclease 3-pyrimidinooligonucleotidohydrolaseribonuclease3-pyrimidinooligonucleotidohydrolaseribonuclease-3-pyrimidinooligonucleotidohydrolaseendoribonuclease I3'-pyrimidino-oligonucleotidohydrolaseribonucleate 3'-pyrimidino-oligonucleotidohydrolase
02

Targets

vRNA (Coronavirus viral RNA)

Beyond the preview

Go deeper on ribonuclease A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribonuclease A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call